<DOC>
	<DOCNO>NCT01094717</DOCNO>
	<brief_summary>The hypothesis study excimer ( 308-nm UVB ) laser add either tazarotene 0.1 % gel acitretin 25 mg daily lead improve efficacy treatment alone . The primary objective study compare improvement psoriatic plaque without excimer laser ( 308-nm UVB ) treatment , apply randomize blinded fashion , subject acitretin 25 mg tazarotene gel 0.1 % QD . The primary endpoint comparison change NPF score plaque treat excimer laser treat sham treatment . The secondary objective compare number excimer light treatment time necessary achieve average lesion assessment score 0 1 subject treat acitretin 25 mg PO tazarotene gel 0.1 % QD , evaluate adverse event related combination study treatment .</brief_summary>
	<brief_title>Acitretin Tazarotene Gel Excimer Laser Treatment Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Must give write informed consent Must least 18 year old Must diagnose stable plaque type psoriasis cover 1 5 % BSA NPFPS â‰¥8 ( base additive score average lesion erythema , scale , thickness range score = 05 ) No systemic phototherapy 4 wks prior enter study No topical therapy emollient ( corticosteroid , vitamin D analog , vitamin A analog ) 2 wks prior enter study Women tazarotene gel must pregnant plan become pregnant study must two form birth control Subjects know tolerate oral acitretin 25 mg/day woman childbearing potential may enrol treated topical tazarotene gel 0.1 % Candidates exclude study entry follow exclusion criterion exist time enrollment : Unstable disease Only treatable site intertriginous area face Subjects unable tolerate frequency visit NPFPS severity score &lt; 8 additive score erythema , scale , thickness , average lesion History inability tolerate topical tazarotene 0.1 % gel acitretin 25 mg/day Women childbearing potential exclude actretin arm study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>excimer</keyword>
	<keyword>acitretin</keyword>
	<keyword>tazarotene</keyword>
</DOC>